<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2021-66-5-67-74</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-1484</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Роль катионных каналов потенциального рецептора TRPC в патогенезе идиопатического нефротического синдрома детей</article-title><trans-title-group xml:lang="en"><trans-title>The role of cationic channels of the potential TRPC receptor in the pathogenesis of idiopathic nephrotic syndrome in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0942-0103</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Морозов</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Morozov</surname><given-names>S. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Морозов Сергей Леонидович – к.м.н., ст. науч. сотр. отдела наследственных и приобретенных болезней почек им. профессора М.С. Игнатовой; доц. кафедры госпитальной педиатрии №2 педиатрического факультета </p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">mser@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0942-0103</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Длин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dlin</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Длин Владимир Викторович – д.м.н., проф., рук. отдела наследственных и приобретенных болезней почек им. профессора М.С. Игнатовой, дир.</p><p>125412 Москва, ул. Талдомская, д. 2</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ОСП «Научно-исследовательский клинический институт педиатрии им. академика Ю.Е. Вельтищева» ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России; ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Veltischev Research and Clinical Institute for Pediatrics at the Pirogov Russian National Research Medical University; Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ОСП «Научно-исследовательский клинический институт педиатрии им. академика Ю.Е. Вельтищева» ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Veltischev Research and Clinical Institute for Pediatrics at the Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>08</day><month>12</month><year>2021</year></pub-date><volume>66</volume><issue>5</issue><fpage>67</fpage><lpage>74</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/1484">https://www.ped-perinatology.ru/jour/article/view/1484</self-uri><abstract><p>Идиопатический нефротический синдром – наиболее частая гломерулопатия в детском возрасте, распространенность которой составляет примерно 16 на 100 тыс. детского населения во всем мире. Любое хроническое гломерулярное заболевание имеет в своем роде однотипный механизм развития. Независимо от повреждающего фактора после гибели значительной части нефронов происходит устойчивое снижение скорости клубочковой фильтрации, при этом морфологически чаще всего определяется фокальный сегментарный гломерулосклероз. Изучение причин формирования фокального сегментарного гломерулосклероза составляет актуальную проблему в педиатрической нефрологии. В последнее время обсуждается роль катионных каналов потенциального рецептора TRPC подоцитов в развитии протеинурии и фокального сегментарного гломерулосклероза. В статье приводятся данные о роли рецепторов TRPC в патогенезе фокального сегментарного гломерулосклероза. Приводятся собственные данные, которые демонстрируют экспрессию генов семейства катионных каналов потенциального рецептора TRPC1, TRPC3, TRPC4, TRPC5 и TRPC6 у детей с идиопатическим нефротическим синдромом в зависимости от морфологической картины заболевания и чувствительности к стероидной терапии.</p></abstract><trans-abstract xml:lang="en"><p>Idiopathic nephrotic syndrome is the most common glomerulopathy in children, with a prevalence of approximately 16 per 100,000 of child population worldwide. Any chronic glomerular disease has the same type of development mechanism. Regardless of the damaging factor, after the death of a significant part of the nephrons, there occurs a steady decrease in the glomerular filtration rate, while morphologically we most often determine focal segmental glomerulosclerosis. Studying the causes of focal segmental glomerulosclerosis is an urgent problem in pediatric nephrology. Recently, there has been discussed the role of the cation channels of the potential receptor TRPC of podocytes in the development of proteinuria and focal segmental glomerulosclerosis. The article provides data on the role of TRPC receptors in the pathogenesis of focal segmental glomerulosclerosis. The authors present their our own data demonstrating gene expression of the cationic channels family of the potential receptor TRPC1, TRPC3, TRPC4, TRPC5 and TRPC6 in children with idiopathic nephrotic syndrome, depending on the morphological picture of the disease and sensitivity to steroid therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>нефротический синдром</kwd><kwd>фокальный сегментарный гломерулосклероз</kwd><kwd>экспрессия</kwd><kwd>рецептор TRPC</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>nephrotic syndrome</kwd><kwd>focal segmental glomerulosclerosis</kwd><kwd>expression</kwd><kwd>TRPC receptor</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">работа выполнена в рамках финансирования Госзадания «Клинические и молекулярно-генетический критерии прогнозирования эффективности стероидной и иммуносупрессивной терапии первичного нефротического синдрома у детей» № 200080056</funding-statement><funding-statement xml:lang="en">the work was carried out within the framework of funding from the State Assignment “Clinical and molecular genetic criteria for predicting the effectiveness of steroid and immunosuppressive therapy for primary nephrotic syndrome in children” No. 200080056</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Eddy A.A., Symons J.M. Nephrotic syndrome in childhood. Lancet 2003; 362(9384): 629–639. DOI: 10.1016/S0140-6736(03)14184-0</mixed-citation><mixed-citation xml:lang="en">Eddy A.A., Symons J.M. Nephrotic syndrome in childhood. Lancet 2003; 362(9384): 629–639. DOI: 10.1016/S0140-6736(03)14184-0</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Becherucci F., Roperto R.M., Materassi M., Romagnani P. Chronic kidney disease in children. Clin Kidney J 2016; 9(4):583–591. DOI: 10.1093/ckj/sfw047</mixed-citation><mixed-citation xml:lang="en">Becherucci F., Roperto R.M., Materassi M., Romagnani P. Chronic kidney disease in children. Clin Kidney J 2016; 9(4):583–591. DOI: 10.1093/ckj/sfw047</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Harambat .J, van Stralen K.J., Kim J.J., Tizard E.J. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012; 27(3): 363–373. DOI: 10.1007/s00467-011-1939-1</mixed-citation><mixed-citation xml:lang="en">Harambat .J, van Stralen K.J., Kim J.J., Tizard E.J. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012; 27(3): 363–373. DOI: 10.1007/s00467-011-1939-1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kriz W., Gretz N., Lemley K.V. Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 1998; 54(3):687–697. DOI: 10.1046/j.1523-1755.1998.00044.x</mixed-citation><mixed-citation xml:lang="en">Kriz W., Gretz N., Lemley K.V. Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 1998; 54(3):687–697. DOI: 10.1046/j.1523-1755.1998.00044.x</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pavenstädt H., Kriz W., Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83(1): 253–307. DOI: 10.1152/physrev.00020.2002</mixed-citation><mixed-citation xml:lang="en">Pavenstädt H., Kriz W., Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83(1): 253–307. DOI: 10.1152/physrev.00020.2002</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pollak M.R., Quaggin S.E., Hoenig M.P., Dworkin L.D. The glomerulus: the sphere of influence. Clin J Am Soc Nephrol 2014; 9(8): 1461–1469. DOI: 10.2215/CJN.09400913</mixed-citation><mixed-citation xml:lang="en">Pollak M.R., Quaggin S.E., Hoenig M.P., Dworkin L.D. The glomerulus: the sphere of influence. Clin J Am Soc Nephrol 2014; 9(8): 1461–1469. DOI: 10.2215/CJN.09400913</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wiggins R.C. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71(12): 1205–1214. DOI: 10.1038/sj.ki.5002222</mixed-citation><mixed-citation xml:lang="en">Wiggins R.C. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71(12): 1205–1214. DOI: 10.1038/sj.ki.5002222</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenberg A.Z., Kopp J.B. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol 2017; 12(3): 502–517. DOI: 10.2215/CJN.05960616</mixed-citation><mixed-citation xml:lang="en">Rosenberg A.Z., Kopp J.B. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol 2017; 12(3): 502–517. DOI: 10.2215/CJN.05960616</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gees M., Colsoul B., Nilius B. The role of transient receptor potential cation channels in Ca2+ signaling. Cold Spring Harb Perspect Biol 2010; 2(10): a003962. DOI: 10.1101/cshperspect.a003962</mixed-citation><mixed-citation xml:lang="en">Gees M., Colsoul B., Nilius B. The role of transient receptor potential cation channels in Ca2+ signaling. Cold Spring Harb Perspect Biol 2010; 2(10): a003962. DOI: 10.1101/cshperspect.a003962</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87(1):165–217. DOI: 10.1152/physrev.00021.2006</mixed-citation><mixed-citation xml:lang="en">Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87(1):165–217. DOI: 10.1152/physrev.00021.2006</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ding Y., Winters A., Ding M., Graham S., Akopova I., Muallem S. et al. Reactive oxygen species-mediated TRPC6 protein activation in vascular myocytes, a mechanism for vasoconstrictor-regulated vascular tone. J Biol Chem 2011; 286(36): 31799–31809. DOI: 10.1074/jbc.M111.248344</mixed-citation><mixed-citation xml:lang="en">Ding Y., Winters A., Ding M., Graham S., Akopova I., Muallem S. et al. Reactive oxygen species-mediated TRPC6 protein activation in vascular myocytes, a mechanism for vasoconstrictor-regulated vascular tone. J Biol Chem 2011; 286(36): 31799–31809. DOI: 10.1074/jbc.M111.248344</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kim E.Y., Anderson M., Wilson C., Hagmann H., Benzing T., Dryer S.E. NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complex. Am J Physiol Cell Physiol 2013; 305(9): 960–971. DOI: 10.1152/ajpcell.00191.2013</mixed-citation><mixed-citation xml:lang="en">Kim E.Y., Anderson M., Wilson C., Hagmann H., Benzing T., Dryer S.E. NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complex. Am J Physiol Cell Physiol 2013; 305(9): 960–971. DOI: 10.1152/ajpcell.00191.2013</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Winn M.P., Conlon P.J., Lynn K.L., Farrington M.K., Creazzo T., Hawkins A.F. et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308(5729): 1801–1804. DOI: 10.1126/science.1106215</mixed-citation><mixed-citation xml:lang="en">Winn M.P., Conlon P.J., Lynn K.L., Farrington M.K., Creazzo T., Hawkins A.F. et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308(5729): 1801–1804. DOI: 10.1126/science.1106215</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Reiser J., Polu K.R., Möller CC, Kenlan P, Altintas MM, Wei C. et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37(7): 739–744. DOI: 10.1038/ng1592</mixed-citation><mixed-citation xml:lang="en">Reiser J., Polu K.R., Möller CC, Kenlan P, Altintas MM, Wei C. et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37(7): 739–744. DOI: 10.1038/ng1592</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Huber T.B., Schermer B., Müller R.U., Höhne M., Bartram M., Calixto A. et al. Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci USA 2006; 103(46): 17079–17086. DOI: 10.1073/pnas.0607465103</mixed-citation><mixed-citation xml:lang="en">Huber T.B., Schermer B., Müller R.U., Höhne M., Bartram M., Calixto A. et al. Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci USA 2006; 103(46): 17079–17086. DOI: 10.1073/pnas.0607465103</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu B., Chen N., Wang Z-H., Pan X-X., Ren H., Zhang W. et al. Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients. Mutat Res 2009; 664(1–2): 84–90. DOI: 10.1016/j.mrfmmm.2008.11.021</mixed-citation><mixed-citation xml:lang="en">Zhu B., Chen N., Wang Z-H., Pan X-X., Ren H., Zhang W. et al. Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients. Mutat Res 2009; 664(1–2): 84–90. DOI: 10.1016/j.mrfmmm.2008.11.021</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Büscher A.K., Konrad M., Nagel M., Witzke O., Kribben A., Hoyer P.F. et al. Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients. Clin Nephrol 2012; 78(1): 47–53. DOI: 10.5414/cn107320</mixed-citation><mixed-citation xml:lang="en">Büscher A.K., Konrad M., Nagel M., Witzke O., Kribben A., Hoyer P.F. et al. Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients. Clin Nephrol 2012; 78(1): 47–53. DOI: 10.5414/cn107320</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Heeringa S.F., Möller C.C.,Du J.,Yue L.,Hinkes B.,Chernin G. etal. A novel TRPC6 mutation that causes childhood FSGS. PLoS One 2009; 4(11): e7771. DOI: 10.1371/journal.pone.0007771</mixed-citation><mixed-citation xml:lang="en">Heeringa S.F., Möller C.C.,Du J.,Yue L.,Hinkes B.,Chernin G. etal. A novel TRPC6 mutation that causes childhood FSGS. PLoS One 2009; 4(11): e7771. DOI: 10.1371/journal.pone.0007771</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L., Jirka G., Rosenberg P.B., Buckley A.F., Gomez J.A., Fields T.A. et al. Gq signaling causes glomerular injury by activating TRPC6. J Clin Invest 2015; 125(5): 1913–1926. DOI: 10.1172/JCI76767</mixed-citation><mixed-citation xml:lang="en">Wang L., Jirka G., Rosenberg P.B., Buckley A.F., Gomez J.A., Fields T.A. et al. Gq signaling causes glomerular injury by activating TRPC6. J Clin Invest 2015; 125(5): 1913–1926. DOI: 10.1172/JCI76767</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Möller C.C., Flesche J., Reiser J. Sensitizing the Slit Diaphragm with TRPC6 ion channels. J Am Soc Nephrol 2009; 20(5): 950–953. DOI: 10.1681/ASN.2008030329</mixed-citation><mixed-citation xml:lang="en">Möller C.C., Flesche J., Reiser J. Sensitizing the Slit Diaphragm with TRPC6 ion channels. J Am Soc Nephrol 2009; 20(5): 950–953. DOI: 10.1681/ASN.2008030329</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Möller C.C., Wei C., Altintas M.M., Li J., Greka A., Ohse T. et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 2007; 18(1): 29–36. DOI: 10.1681/ASN.2006091010</mixed-citation><mixed-citation xml:lang="en">Möller C.C., Wei C., Altintas M.M., Li J., Greka A., Ohse T. et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 2007; 18(1): 29–36. DOI: 10.1681/ASN.2006091010</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Krall P., Canales C.P., Kairath P., Carmona-Mora P., Molina J., Carpio J.D. et al. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS One 2010; 5(9): e12859. DOI: 10.1371/journal.pone.0012859</mixed-citation><mixed-citation xml:lang="en">Krall P., Canales C.P., Kairath P., Carmona-Mora P., Molina J., Carpio J.D. et al. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS One 2010; 5(9): e12859. DOI: 10.1371/journal.pone.0012859</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hogan P.G., Chen L., Nardone J., Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003;17(18):2205–2232. DOI: 10.1101/gad.1102703</mixed-citation><mixed-citation xml:lang="en">Hogan P.G., Chen L., Nardone J., Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003;17(18):2205–2232. DOI: 10.1101/gad.1102703</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A. et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 2006; 116(12): 3114–3126. DOI: 10.1172/JCI27702</mixed-citation><mixed-citation xml:lang="en">Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A. et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest 2006; 116(12): 3114–3126. DOI: 10.1172/JCI27702</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Rao A., Hogan P.G. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol 2011;21(2):91–103. DOI: 10.1016/j.tcb.2010.09.011</mixed-citation><mixed-citation xml:lang="en">Li H., Rao A., Hogan P.G. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol 2011;21(2):91–103. DOI: 10.1016/j.tcb.2010.09.011</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ilatovskaya D.V., Staruschenko A. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Am J Physiol Renal Physiol 2015; 309(5): F393–397. DOI: 10.1152/ajprenal.00186.2015</mixed-citation><mixed-citation xml:lang="en">Ilatovskaya D.V., Staruschenko A. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Am J Physiol Renal Physiol 2015; 309(5): F393–397. DOI: 10.1152/ajprenal.00186.2015</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Saliba Y., Karam R., Smayra V., Aftimos G., Abramowitz J., Birnbaumer L. et al. Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis. J Am Soc Nephrol 2015; 26(8): 1855–1876. DOI: 10.1681/ASN.2014010065</mixed-citation><mixed-citation xml:lang="en">Saliba Y., Karam R., Smayra V., Aftimos G., Abramowitz J., Birnbaumer L. et al. Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis. J Am Soc Nephrol 2015; 26(8): 1855–1876. DOI: 10.1681/ASN.2014010065</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
